What is Iverheal?

Iverheal is a brand of Ivermectin 6 mg, a well-known antiparasitic medication. It is used to treat a variety of parasitic infections in humans, including those caused by worms, lice, and mites. Iverheal is available in various dosages, such as 3 mg, 6 mg, and 12 mg, depending on the severity of the infection being treated.

Clinical Uses of Iverheal

Iverheal is primarily prescribed for the treatment of:

• Onchocerciasis (River Blindness): Caused by the parasitic worm Onchocerca volvulus.
• Strongyloidiasis: An intestinal infection caused by the roundworm Strongyloides stercoralis.
• Scabies: A skin infestation caused by mites, leading to intense itching and rash.
• Pediculosis (Lice Infestations): Effective in treating infestations of head and pubic lice.

Mechanism of Action

Iverheal works by binding to glutamate-gated chloride channels found in the nerve and muscle cells of parasites. This action increases the permeability of cell membranes to chloride ions, leading to paralysis and death of the parasite, which allows the body to clear the infection.

Dosage and Administration

The dosage of Iverheal depends on the condition being treated, as well as the patient’s weight and overall health. It is usually taken as a single oral dose with water on an empty stomach. In some cases, additional doses may be necessary, as directed by a healthcare provider.

Precautions and Side Effects

Before taking Iverheal, it is important to inform your healthcare provider about any other medications you are taking and any underlying health conditions. Common side effects of Iverheal include dizziness, nausea, and diarrhea. Serious side effects are rare but may include neurological symptoms or allergic reactions. Immediate medical attention is required if severe side effects occur.

Iverheal and COVID-19

Iverheal, like other forms of Ivermectin, gained attention during the COVID-19 pandemic as a potential treatment for the virus. However, major health authorities such as the FDA and WHO have not endorsed its use for COVID-19 due to a lack of sufficient evidence supporting its effectiveness and safety in this context.

Conclusion

Iverheal is an effective antiparasitic medication for treating specific parasitic infections. While it has been discussed in relation to COVID-19, its use for this purpose is not recommended by health authorities. Iverheal should be used under the guidance of a healthcare provider for approved indications only.